Iguana Healthcare Management’s Puma Biotechnology PBYI Stock Holding History

Iguana Healthcare Management’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-17,500	Closed	-$1.73M	–	67
2017 Q4	$1.73M	Buy	+17,500	New	+$1.96M	1.13%	34
2016 Q2	–	Sell	-30,000	Closed	-$881K	–	97
2016 Q1	$881K	Buy	30,000 +5,000	+20%	+$226K	0.32%	62
2015 Q4	$1.96M	Buy	+25,000	New	+$1.96M	0.64%	47
2015 Q2	–	Sell	-25,000	Closed	-$5.9M	–	84
2015 Q1	$5.9M	Buy	25,000 +15,000	+150%	+$3.21M	2.48%	10
2014 Q4	$1.89M	Hold	10,000	–	–	0.91%	39
2014 Q3	$2.39M	Sell	10,000 -17,500	-64%	-$3.59M	1.27%	32
2014 Q2	$1.81M	Sell	27,500 -7,500	-21%	-$533K	0.85%	43
2014 Q1	$3.65M	Buy	35,000 +10,000	+40%	+$1.18M	1.69%	20
2013 Q4	$2.59M	Buy	+25,000	New	+$1.47M	1.48%	24

Other funds holding PBYI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Iguana Healthcare Management's PBYI Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Puma Biotechnology (PBYI) in Q1 2018, closing a stake of 17,500 shares — an estimated $1.73M sold.

Iguana Healthcare Management first reported a position in PBYI in Q4 2013 and held it in 9 quarters. The position peaked at $5.9M in Q1 2015. 178 funds tracked by Wall St. Rank hold PBYI as of Q1 2018.

Iguana Healthcare Management reported no remaining Puma Biotechnology position as of Q1 2018 after selling out during the quarter.
Iguana Healthcare Management sold 17,500 Puma Biotechnology shares in Q1 2018, an estimated $1.73M.
Iguana Healthcare Management first reported a position in Puma Biotechnology in Q4 2013 and held it in 9 quarters.
Iguana Healthcare Management's Puma Biotechnology position peaked at $5.9M in Q1 2015.
178 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.